Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
EMMA Walmsley, GlaxoSmithKline's incoming CEO, will take over Britain's biggest drugmaker at a challenging time but the 47-year-old also inherits the flexibility to do deals and make key choices on new drugs.
Just four days before she moves into the top job on April 1, US...